Literature DB >> 12603263

Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals.

Munmun Chattopadhyay1, James Goss, David Lacomis, William C Goins, Joseph C Glorioso, Marina Mata, David J Fink.   

Abstract

The distinct distribution of trkA receptors on small neurons and trkC receptors on large neurons in the dorsal root ganglion correlates with the dependence of these two classes of neurons on nerve growth factor and neurotrophin-3, respectively, for survival during development. In adult animals, the distribution of high affinity neurotrophin (trk) is complex and overlapping; neurotrophins are not required for cell survival, but may influence cell phenotype and the response to injury. In order to test the functional activity of trkA receptors in the sensory ganglia of adult animals in vivo, we examined the ability of a nerve growth factor-expressing recombinant replication-defective herpes simplex virus-based vector to prevent the selective degeneration of large sensory fibres caused by intoxication with pyridoxine. Transduction of dorsal root ganglion neurons in vivo by subcutaneous inoculation of the nerve growth factor-expressing vector prevented the development of pyridoxine-induced neuropathy measured by electrophysiological, morphological and behavioural measures. These results demonstrate a functional activity of trkA receptors expressed on large neurons in the dorsal root ganglion in mature animals; this observation has important implications for the choice of neurotrophic factors for treatment of peripheral nerve disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603263     DOI: 10.1046/j.1460-9568.2003.02500.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  14 in total

Review 1.  Gene therapy: novel treatments for polyneuropathy and chronic pain.

Authors:  Marina Mata; Joseph C Glorioso; David J Fink
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

Review 2.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

3.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

Review 4.  Progress in gene therapy for neurological disorders.

Authors:  Michele Simonato; Jean Bennett; Nicholas M Boulis; Maria G Castro; David J Fink; William F Goins; Steven J Gray; Pedro R Lowenstein; Luk H Vandenberghe; Thomas J Wilson; John H Wolfe; Joseph C Glorioso
Journal:  Nat Rev Neurol       Date:  2013-04-23       Impact factor: 42.937

5.  Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neurons.

Authors:  Munmun Chattopadhyay; Marina Mata; David J Fink
Journal:  Eur J Pain       Date:  2011-04-12       Impact factor: 3.931

6.  HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy.

Authors:  M Chattopadhyay; D Krisky; D Wolfe; J C Glorioso; M Mata; D J Fink
Journal:  Gene Ther       Date:  2005-09       Impact factor: 5.250

Review 7.  Therapeutic gene transfer to the nervous system using viral vectors.

Authors:  Joseph C Glorioso; Marina Mata; David J Fink
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

8.  Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.

Authors:  R Kato; D Wolfe; C H Coyle; J B Wechuck; P Tyagi; T Tsukamoto; J B Nelson; J C Glorioso; M B Chancellor; N Yoshimura
Journal:  Gene Ther       Date:  2008-07-31       Impact factor: 5.250

Review 9.  Gene therapy for the treatment of diabetic neuropathy.

Authors:  Marina Mata; Munmun Chattopadhyay; David J Fink
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

10.  In vitro and in vivo gene therapy with CMV vector-mediated presumed dog beta-nerve growth factor in pyridoxine-induced neuropathy dogs.

Authors:  Jin Young Chung; Jung Hoon Choi; Il Seob Shin; Eun Wha Choi; Cheol Yong Hwang; Sang Koo Lee; Hwa Young Youn
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.